Business Description
DarioHealth Corp
NAICS : 923120
SIC : 7372
ISIN : US23725P3082
Total Employee Number:
165Description
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.63 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | -1.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -6.35 | |||||
Beneish M-Score | -3.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37.9 | |||||
3-Year EBITDA Growth Rate | 42.6 | |||||
3-Year EPS without NRI Growth Rate | 41.3 | |||||
3-Year FCF Growth Rate | 45.7 | |||||
3-Year Book Growth Rate | -45.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 53.01 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 34.76 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 11.46 | |||||
9-Day RSI | 17.27 | |||||
14-Day RSI | 25.46 | |||||
3-1 Month Momentum % | 1.29 | |||||
6-1 Month Momentum % | -21.71 | |||||
12-1 Month Momentum % | -45.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.07 | |||||
Quick Ratio | 2.62 | |||||
Cash Ratio | 2.14 | |||||
Days Inventory | 179.08 | |||||
Days Sales Outstanding | 43.06 | |||||
Days Payable | 126.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -75.1 | |||||
Shareholder Yield % | -2.95 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.55 | |||||
Operating Margin % | -163.07 | |||||
Net Margin % | -192.23 | |||||
EBITDA Margin % | -146.27 | |||||
FCF Margin % | -120.03 | |||||
OCF Margin % | -119.36 | |||||
ROE % | -59.4 | |||||
ROA % | -36.7 | |||||
ROIC % | -43.27 | |||||
3-Year ROIIC % | 192.12 | |||||
ROC (Joel Greenblatt) % | -2463.35 | |||||
ROCE % | -33.53 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.13 | |||||
PB Ratio | 0.71 | |||||
EV-to-EBIT | -1.68 | |||||
EV-to-EBITDA | -1.81 | |||||
EV-to-Revenue | 2.65 | |||||
EV-to-Forward-Revenue | 2.25 | |||||
EV-to-FCF | -2.21 | |||||
Price-to-GF-Value | 0.85 | |||||
Price-to-Median-PS-Value | 0.39 | |||||
Earnings Yield (Greenblatt) % | -59.52 | |||||
FCF Yield % | -57.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DRIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DarioHealth Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 21.191 | ||
| EPS (TTM) ($) | -9.295 | ||
| Beta | 1.0796 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.81 | ||
| Volatility % | 102.91 | ||
| 14-Day RSI | 25.46 | ||
| 14-Day ATR ($) | 0.470392 | ||
| 20-Day SMA ($) | 7.21948 | ||
| 12-1 Month Momentum % | -45.26 | ||
| 52-Week Range ($) | 5.85 - 17.7437 | ||
| Shares Outstanding (Mil) | 7.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DarioHealth Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DarioHealth Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 08:30 | In 142 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 141 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 08:30 | In 49 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 48 days | ||
| First quarter earnings conference call for 2026 | 2026-05-13 08:30 | 8.68 (+7.83%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 8.68 (+7.83%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-19 08:30 | 8.93 (-0.78%) | ||
| Annual report for 2025 | 2026-03-19 | 8.93 (-0.78%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-19 | 8.93 (-0.78%) | ||
| General meeting for 2025 | 2026-01-29 16:00 | 10.96 (+1.39%) |
Show
Entries
DarioHealth Corp Frequently Asked Questions
What is DarioHealth Corp(DRIO)'s stock price today?
The current price of DRIO is $6.06. The 52 week high of DRIO is $17.74 and 52 week low is $5.85.
When is next earnings date of DarioHealth Corp(DRIO)?
The next earnings date of DarioHealth Corp(DRIO) is 2026-08-12 Est..
Does DarioHealth Corp(DRIO) pay dividends? If so, how much?
DarioHealth Corp(DRIO) does not pay dividend.
Guru Commentaries on NAS:DRIO
No articles.
Press Release
Articles on DarioHealth Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers